285 related articles for article (PubMed ID: 9560736)
1. Macrolide antibiotics.
Pallasch TJ
Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for acute orofacial infections.
Pallasch TJ
J Calif Dent Assoc; 1993 Feb; 21(2):34-44. PubMed ID: 7693890
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin and azithromycin: new macrolide antibiotics.
Piscitelli SC; Danziger LH; Rodvold KA
Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
[TBL] [Abstract][Full Text] [Related]
4. The newer macrolides. Azithromycin and clarithromycin.
Zuckerman JM; Kaye KM
Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
[TBL] [Abstract][Full Text] [Related]
5. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
6. [New macrolides].
Portier H; Buisson M; Chavanet P
Rev Prat; 1994 Jun; 44(12):1629-34. PubMed ID: 7939238
[TBL] [Abstract][Full Text] [Related]
7. 4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens.
Fajdetić A; Cipcić Paljetak H; Lazarevski G; Hutinec A; Alihodzić S; Derek M; Stimac V; Andreotti D; Sunjić V; Berge JM; Mutak S; Dumić M; Lociuro S; Holmes DJ; Marsić N; Eraković Haber V; Spaventi R
Bioorg Med Chem; 2010 Sep; 18(17):6559-68. PubMed ID: 20634078
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics and their use in the treatment of orofacial infections, Part I.
Wynn RL; Bergman SA
Gen Dent; 1994; 42(5):398, 400, 402. PubMed ID: 7489869
[No Abstract] [Full Text] [Related]
10. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
Yeates RA; Laufen H; Zimmermann T; Schumacher T
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin, erythromycin, and the newer macrolides.
Raebel MA; Browne BA
Clin Podiatr Med Surg; 1992 Apr; 9(2):409-23. PubMed ID: 1586909
[TBL] [Abstract][Full Text] [Related]
13. Dirithromycin: a new macrolide.
Wintermeyer SM; Abdel-Rahman SM; Nahata MC
Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
[TBL] [Abstract][Full Text] [Related]
14. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
Peltier K
Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin and clarithromycin: overview and comparison with erythromycin.
Whitman MS; Tunkel AR
Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
Ito K; Ogihara K; Kanamitsu S; Itoh T
Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973
[TBL] [Abstract][Full Text] [Related]
18. The new macrolides: expanding the ways in antibiotic treatment.
Avilés Santa ML; Ramírez-Ronda CH
Bol Asoc Med P R; 1992 Jan; 84(1):21-5. PubMed ID: 1503585
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
20. [Macrolides, a group of antibiotics with a broad spectrum of activity].
Hof H
Immun Infekt; 1994 Apr; 22(2):66-71. PubMed ID: 7959864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
